弥漫大B细胞淋巴瘤中医证候、证素动态分布规律及与化疗结局相关性OA
Dynamic Evolution of Chinese Medicine Patterns and Pattern Elements in Diffuse Large B-Cell Lymphoma and Its Correlation with Chemotherapy Outcomes
目的 探讨弥漫大B细胞淋巴瘤(DLBCL)中医证候、证素动态分布规律及证候与化疗结局的相关性.方法 纳入2023年1月—2024年12月就诊于福建中医药大学附属第三人民医院血液科DLBCL患者,于初治(化疗前)、中期(R-CHOP方案4周期后)及结疗(R-CHOP方案8周期后)三个时间点采集四诊信息,提取证素并进行中医辨证分型,分析各证候临床指标差异、证候及证素动态分布,及其与化疗结局的相关性.结果 共纳入412例次(初治286例、中期95例、结疗31例).五种证候呈动态演变:阴虚痰结证初治占比高(39.2%),随治疗减少(中期29.5%,结疗19.3%);正虚邪恋证初治占比低(3.2%),随治疗增多(中期33.7%,结疗32.3%);气郁痰阻证各期占比稳定(21.1%~32.3%),寒痰凝滞证与痰瘀毒蕴证各阶段均占比较少.证素方面,寒痰凝滞证以正虚为主,痰瘀毒蕴证以邪实为主,阴虚痰结证为阴虚有热象,气郁痰阻证为气滞病位在肝,正虚邪恋证为正虚病位在脾.痰瘀毒蕴证与阴虚痰结证β2-微球蛋白(β2-MG)及中性粒细胞计数(NEUT)水平较高,血小板计数(PLT)水平较低(P<0.05),正虚邪恋证β2-MG水平较低,PLT水平较高(P<0.05).中医证候与化疗中期结局相关(P<0.05,Cramer's V=0.330),痰瘀毒蕴证PR率较低(0/7),PD率较高(4/7);与化疗结疗结局间无统计显著性关联(P>0.05),但存在中等效应量(Cramer's V=0.432).结论 DLBCL五种中医证候呈动态演变,各证候的证素组成在不同阶段大体一致.证候与化疗中期结局相关,与结疗结局无显著性关联.符合DLBCL"始于气,成于痰,痰气瘀交结"病理特点的证型预后相对较好.
Objective To investigate the dynamic distribution patterns of Chinese medicine(CM)patterns and pattern elements in diffuse large B-cell lymphoma(DLBCL),as to explore the correlation between CM patterns and chemotherapy outcomes.Methods DLBCL patients treated at the Department of Hematology,The Third Affiliated Hospital of Fujian University of Traditional Chinese Medicine,from January 2023 to December 2024 were enrolled.Syndrome differentiation information was collected at three time points:initial treatment(before chemotherapy),mid-chemotherapy(after 4 cycles of R-CHOP regimen),and end-of-chemotherapy(after 8 cycles of R-CHOP regimen).Pattern elements were extracted,and CM pattern differentiation was performed.Differences in clinical indicators among different patterns,the dynamic distribution of patterns and pattern elements,and their correlation with mid-and end-of-chemotherapy outcomes were analyzed.Results A total of 412 patient visits were included(286 at initial treatment,95 at mid-chemotherapy,and 31 at end-of-chemotherapy).Five CM patterns showed dynamic evolution:Yin deficiency with phlegm accumulation pattern had the highest proportion at initial treatment(39.2%),which decreased over time(29.5%at mid-chemotherapy,19.3%at end-of-chemotherapy);vital qi deficiency with lingering pathogen pattern showed the lowest proportion at initial treatment(3.2%),which increased during treatment(33.7%at mid-chemotherapy,32.3%at end-of-chemotherapy);qi depression with phlegm obstruction pattern remained stable across stages(21.1%~32.3%);whereas cold-phlegm congelation and stagnation pattern and phlegm-blood stasis toxin pattern accounted for smaller proportions across all stages.Regarding pattern elements distribution,cold-phlegm congelation and stagnation pattern was dominated by vital qi deficiency;phlegm-blood stasis toxin pattern was dominated by excess pathogen;yin deficiency with phlegm accumulation pattern manifested as yin deficiency with heat signs;qi depression with phlegm obstruction pattern manifested as qi stagnation with the Gan as the disease location;lingering pathogen due to deficient vital qi pattern manifested as vital qi deficiency with the Pi as the disease location.Clinically,the phlegm-blood stasis toxin pattern and yin deficiency with phlegm accumulation pattern exhibited higher levels of Beta-2 microglobulin(β2-MG)and neutrophil count(NEUT)and lower platelet count(PLT)levels(P<0.05),while the vital qi deficiency with lingering pathogen pattern showed lower β2-MG and higher PLT levels(P<0.05).CM patterns were significantly associated with mid-chemotherapy outcomes(P<0.05,Cramer's V=0.330),with the phlegm-blood stasis toxin pattern showing a lower PR rate(0/7)and a higher PD rate(4/7)compared to other patterns.No statistically significant association was observed between CM patterns and end-of-chemotherapy outcomes(P>0.05),although a moderate effect size was observed(Cramer's V=0.432).Conclusions Five CM patterns in DLBCL exhibit dynamic evolution,while the composition of pattern elements remains relatively stable across treatment stages.CM patterns are significantly associated with mid-chemotherapy outcomes but not with end-of-chemotherapy outcomes.Patterns conforming to the pathophysiological characteristics of DLBCL"originating from qi,developing into phlegm,and culminating in phlegm-stasis interlocking"are associated with relatively favorable prognosis.
李晗婧;曹治云;卓泽伟;陈旭征;郑锖锖;黄冰榆;王顺永;刘庭波;付海英
福建中医药大学附属第三人民医院血液科(福州 350122)||福建中医药大学附属第三人民医院李灿东全国名中医工作室(福州 350122)福建中医药大学中西医结合研究院(福州 350122)||福建省中西医结合老年性疾病重点实验室(福州 350122)||福建省高校中西医结合基础重点实验室(福州 350122)福建中医药大学附属第三人民医院血液科(福州 350122)||福建中医药大学附属第三人民医院李灿东全国名中医工作室(福州 350122)福建中医药大学中西医结合研究院(福州 350122)||福建省中西医结合老年性疾病重点实验室(福州 350122)||福建省高校中西医结合基础重点实验室(福州 350122)福建中医药大学附属第三人民医院血液科(福州 350122)福建中医药大学附属第三人民医院血液科(福州 350122)福建中医药大学附属第三人民医院血液科(福州 350122)福建医科大学附属协和医院血液科(福州 350001)福建中医药大学附属第三人民医院血液科(福州 350122)
弥漫大B细胞淋巴瘤中医证候证素动态演变痰证R-CHOP方案化疗结局
diffuse large B-cell lymphomaChinese medicine patternpattern elementdynamic evolutionphlegm patternR-CHOP regimenchemotherapy outcome
《中国中西医结合杂志》 2026 (9)
1055-1060,6
国家自然科学基金资助项目(No.82274268)2024年福建省西学中高级人才研修项目(No.闽卫中医二函[2024]1969)福建省中医药重点学科建设项目(No.闽卫中医二函[2024]363)福建省卫生健康省级补助资金(No.闽财指[2024]0881)
评论